NCT06782711

Brief Summary

The goal of this clinical trial is to determine the efficacy and safety of customized skull implants made of polyetheretheretherketone by three-dimensional printing in patients undergoing cranioplasty. The main question it aims to answer is:

  • Are customized skull implants made of polyetheretheretherketone using 3D printing effective and safe in patients undergoing cranioplasty? Participants will:
  • The patient will be submitted to cranioplasty.
  • The patient will answer the neurological scales at each visit.
  • Keep a diary of their symptoms and concomitant medications
  • The study will be divided into 5 visits to the center, the surgical intervention and 3 telephone calls where patients will be followed up.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jan 2025Sep 2026

Study Start

First participant enrolled

January 1, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

9 months

First QC Date

January 8, 2025

Last Update Submit

January 16, 2025

Conditions

Keywords

CranioplastyCustom implantsPolyetheretheretherketone (PEEK)Three-dimensional (3D) printingNeurosurgeryCranial prosthesesMedical devices

Outcome Measures

Primary Outcomes (1)

  • Frequency and causes of cranioplasty revisions

    Cranioplasty revision is performed when it is necessary to correct or adjust a previously placed implant, either due to complications adjust a previously placed implant, either due to complications, lack of integration of the implant or changes in the desired form and function.

    From enrollment to the end of treatment at 12 months

Secondary Outcomes (10)

  • Infection at the implant site

    From enrollment to 3 months after surgery

  • Frequency of surgery-associated infections

    From enrollment to 3 months after surgery

  • Frequency of implant exposure

    From enrollment to the end of treatment at 12 months

  • Frequency and type of implant fractures

    From enrollment to the end of treatment at 12 months

  • Level of consciousness

    From enrollment to 3 months after surgery

  • +5 more secondary outcomes

Study Arms (1)

cranioplasty using customized skull implants made of polyetheretheretherketone using 3D printing

EXPERIMENTAL

All participants will undergo cranioplasty using customized skull implants made of polyetheretheretherketone using 3D printing

Procedure: cranioplastyDevice: customized skull implants made of polyetheretheretherketone (PEEK) using 3D printing

Interventions

cranioplastyPROCEDURE

In this pivotal study of a medical device, patients with bone loss undergo a computed tomography scan, which is used to create a three-dimensional model of the lesion. After validation, the model is printed using PEEK material, and subsequently, the skull is repaired through cranial reconstruction (cranioplasty).

cranioplasty using customized skull implants made of polyetheretheretherketone using 3D printing

customized skull implants made of polyetheretheretherketone by three-dimensional printing in patients undergoing cranioplasty

cranioplasty using customized skull implants made of polyetheretheretherketone using 3D printing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults \>18 years old.
  • Both sexes.
  • Who agree to participate and sign the informed consent form.
  • With loss of a bone segment.
  • Area of bone segment loss greater than 1 cm.
  • Glasgow Coma Scale score equal to or greater than 9.
  • Satisfactory preoperative evaluation

You may not qualify if:

  • Presence of local infection at the craniotomy site or any type of systemic infection at the time of medical evaluation and systemic infection at the time of medical evaluation and during surgery.
  • Presence of previous surgical instruments in the cranioplasty site.
  • Need to use two or more implants for the reconstruction.
  • The resulting angle between the tangential lines to the curvature of the implant and the tangent determined to the center of the implant, determined to the center of the implant, is greater than 50º.
  • Patients whose cranial morphology presents difficulties for the prosthesis design.
  • Presence of postoperative ossifications in the defect area.
  • History of hypersensitivity to biomaterials.
  • Surgery at the same site within the 6 months prior to the study surgery.
  • Patients with any diagnosis that affects blood supply and bone quality.
  • Patients who have received chemotherapy or radiotherapy in the surgical region that ended within 6 months prior to the planned surgery or are scheduled for the next 12 weeks.
  • Diagnosis of malignant cranial tumor.
  • History of any status epilepticus.
  • Known history of hemophilia or other clinically significant coagulopathy.
  • Patients with uncontrolled diabetes according to, ADA criteria:
  • o fasting glucose ≥ 200 mg/dL, HbA1C ≥ 8.5% in the last 3 months.
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Investigación Clínica y Medicina Traslacional (CIMET)

Guadalajara, Jalisco, 44340, Mexico

Location

Related Publications (7)

  • Yang J, Sun T, Yuan Y, Li X, Yu H, Guan J. Evaluation of titanium mesh cranioplasty and polyetheretherketone cranioplasty: protocol for a multicentre, assessor-blinded, randomised controlled trial. BMJ Open. 2019 Dec 3;9(12):e033997. doi: 10.1136/bmjopen-2019-033997.

    PMID: 31796495BACKGROUND
  • Sharma N, Aghlmandi S, Dalcanale F, Seiler D, Zeilhofer HF, Honigmann P, Thieringer FM. Quantitative Assessment of Point-of-Care 3D-Printed Patient-Specific Polyetheretherketone (PEEK) Cranial Implants. Int J Mol Sci. 2021 Aug 7;22(16):8521. doi: 10.3390/ijms22168521.

    PMID: 34445228BACKGROUND
  • Mozaffari K, Rana S, Chow A, Mahgerefteh N, Duong C, Sheppard JP, Phillips HW, Jarrahy R, Yang I. Customized polyetheretherketone (PEEK) implants are associated with similar hospital length of stay compared to autologous bone used in cranioplasty procedures. J Neurol Sci. 2022 Mar 15;434:120169. doi: 10.1016/j.jns.2022.120169. Epub 2022 Jan 24.

    PMID: 35134672BACKGROUND
  • Henry J, Amoo M, Taylor J, O'Brien DP. Complications of Cranioplasty in Relation to Material: Systematic Review, Network Meta-Analysis and Meta-Regression. Neurosurgery. 2021 Aug 16;89(3):383-394. doi: 10.1093/neuros/nyab180.

    PMID: 34100535BACKGROUND
  • Csamer L, Csernatony Z, Novak L, Kovari VZ, Kovacs AE, Soosne Horvath H, Mano S. Custom-made 3D printing-based cranioplasty using a silicone mould and PMMA. Sci Rep. 2023 Jul 25;13(1):11985. doi: 10.1038/s41598-023-38772-9.

    PMID: 37491550BACKGROUND
  • Basgul C, Yu T, MacDonald DW, Siskey R, Marcolongo M, Kurtz SM. Structure-Property Relationships for 3D printed PEEK Intervertebral Lumbar Cages Produced using Fused Filament Fabrication. J Mater Res. 2018 Jul 27;33(14):2040-2051. doi: 10.1557/jmr.2018.178. Epub 2018 Jun 18.

    PMID: 30555210BACKGROUND
  • Alkhaibary A, Alharbi A, Alnefaie N, Oqalaa Almubarak A, Aloraidi A, Khairy S. Cranioplasty: A Comprehensive Review of the History, Materials, Surgical Aspects, and Complications. World Neurosurg. 2020 Jul;139:445-452. doi: 10.1016/j.wneu.2020.04.211. Epub 2020 May 6.

    PMID: 32387405BACKGROUND

Study Officials

  • Geannyne Villegas Rivera, MD, PhD, MBA

    Centro de Investigación Clínica y Medicina Traslacional (CIMET)

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2025

First Posted

January 20, 2025

Study Start

January 1, 2025

Primary Completion

October 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

January 20, 2025

Record last verified: 2025-01

Locations